share

Ensartinib (X-396) CAS NO 1370651-20-9


Unit Price:

CAS No.:1370651-20-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Ensartinib (X-396) is a potent, selective, and orally bioavailable small-molecule inhibitor of anaplastic lymphoma kinase (ALK). This compound matters as a key pharmaceutical intermediate and reference standard in the research and development of targeted cancer therapies, particularly for non-small cell lung cancer (NSCLC). It is needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions focused on oncology drug discovery and clinical studies.

Application

  • Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of advanced investigational drugs targeting ALK-positive cancers.
  • Reference Standard: Used for analytical method development, validation, and quality control in pharmaceutical manufacturing and regulatory submissions.
  • Biochemical Research: Employed in in vitro studies to investigate ALK signaling pathways, kinase selectivity profiles, and mechanisms of drug resistance.
  • Preclinical Development: Utilized in pharmacokinetic (PK), pharmacodynamic (PD), and toxicology studies to support Investigational New Drug (IND) applications.
  • Clinical Trial Material (CTM): Supplied as a high-purity active pharmaceutical ingredient (API) for the formulation of drugs used in clinical trials.

Basic Information

Product Name Ensartinib (X-396)
CAS No. 1370651-20-9
Molecular Formula C₂₇H₃₂ClN₅O₃
Molecular Weight 510.03 g/mol
Synonyms X-396; X396; Ensartinib; (R)-11-(4-(4-(2-((2-Chloro-4-((2-(dimethylamino)ethyl)(methyl)amino)phenyl)amino)-5-methylpyrimidin-4-yl)piperazin-1-yl)piperidin-1-yl)-12-ethyl-4-hydroxy-1,11-dioxo-2,3,4,10-tetrahydro-1H-1,10,4a-triazadibenzo[cd,f]azulen-8(11H)-one; UNII-9Q0B7F8F5P
EINECS Contact for details

Quality Control

Our Ensartinib (X-396) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical research and development. Certificates of Analysis (COA) with detailed HPLC chromatograms and impurity profiles are provided to support your regulatory and quality needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature, 15-25°C (59-77°F). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (IR) Conforms to structure
Assay (HPLC) ≥98.0%
Purity (HPLC, Area%) ≥99.0%
Single Unknown Impurity ≤0.5%
Total Impurities ≤1.0%
Residual Solvents (GC) Complies with ICH Q3C
Water Content (KF) ≤0.5%
Heavy Metals ≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.